XERS position history
The shares of Xeris Biopharma (XERS) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 104,410 shares, $606K, 0.09% of portfolio, New
- 2026 Q2: 104,410 shares, $827K, 0.11% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|